Intracavitary chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is not superior to TKI monotherapy in controlling malignant pleural effusion recurrence in EGFR-mutated lung cancer patients
Wang, Wenxian, Jiang, Xiaowen, Zhang, Yiping, Song, Yong, Song, ZhengboVolume:
11
Journal:
Journal of Thoracic Disease
DOI:
10.21037/jtd.2019.09.36
Date:
September, 2019
File:
PDF, 283 KB
2019